Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-19 @ 3:35 PM
Study NCT ID:
NCT02150967
Status:
TERMINATED
Last Update Posted:
2023-07-03
First Post:
2014-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Sponsor:
QED Therapeutics, a BridgeBio company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CBGJ398X2204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |